TheNFAPost Podcast
2

Instead of removing tumors or blood clots by hand, the surgeon can maneuver the needle through the patient’s brain tissue and can shoot water at the tumor to break it up.

 

Tel Aviv, NFAPost: The new Israeli startup, Tamar Robotics, is developing innovative technology that could help minimise unintentional damage during brain surgery, according to a statement by the Technion.

The company’s technology uses a small needle, inserted through a minor incision and controlled remotely by the surgeon, to perform operations.

Surgical procedure

Tamar Robotics is developing a robotic system that enables patients to benefit from the clinical advantages afforded by craniotomy without the disadvantages associated with this surgical procedure.

Moshe-Shoham-Mazor (Pic Credit: Times of Israel)

A truly minimally invasive solution, TamarRS offers small-diameter access corridor together with high accuracy that does not require multiple intraoperative MRI/CT scans.

The system can treat challenging mass types and locations and offers a reduction in complications, shorter recovery time and shorter hospitalization.

Blood clots

Instead of removing tumors or blood clots by hand, the surgeon can maneuver the needle through the patient’s brain tissue and can shoot water at the tumor to break it up.

The Technion prides itself on the brainpower it can bring to problems – and few are as challenging as actual brain surgery. Tamar Robotics once again shows how Israel is turning science fiction into science fact,” Alan Aziz, CEO of Technion UK complimented the startup.

While typical brain surgery requires the utmost precision and carries a high risk of paralysis other permanent brain damage, Tamar Robotics is aiming to create a safer alternative.

The company was co-founded by Professor Moshe Shoham of the Technion and his former graduate student, Dr. Hadad Ziso.

TamarRS will offer the hospital neurosurgery unit a single robotic system that will address a wide range of neurosurgical procedures.

Protective hood

Tamar recentlu announced that it has developed and deployed a novel protective patient hood that prevents the spread of Covid-19 and protects medical teams when applying non-invasive ventilation therapy for Covid-19 patients.

Tamar NIV is part of the Tamar group of companies, which includes Tamar Robotics Ltd., a company developing a cutting-edge robotic system to offer high-accuracy minimally invasive brain surgery.

The rapid development and initial installation of the NIV Greenhouse™ was a result of the call to action of the Tamar R&D and Engineering teams with the encouragement of Tamar’s investors Professor Moshe Shoham, Mivtach Shamir and the Technion-Israel Institute of Technology.

(The story is based on inputs from Jerusalem Post)

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here